收费全文 | 86352篇 |
免费 | 10322篇 |
国内免费 | 4835篇 |
耳鼻咽喉 | 904篇 |
儿科学 | 1507篇 |
妇产科学 | 720篇 |
基础医学 | 4848篇 |
口腔科学 | 1906篇 |
临床医学 | 11672篇 |
内科学 | 8561篇 |
皮肤病学 | 1183篇 |
神经病学 | 2312篇 |
特种医学 | 3696篇 |
外科学 | 7519篇 |
综合类 | 22061篇 |
现状与发展 | 13篇 |
预防医学 | 11352篇 |
眼科学 | 1032篇 |
药学 | 9150篇 |
116篇 | |
中国医学 | 8594篇 |
肿瘤学 | 4363篇 |
2024年 | 379篇 |
2023年 | 1386篇 |
2022年 | 2727篇 |
2021年 | 3478篇 |
2020年 | 3169篇 |
2019年 | 1658篇 |
2018年 | 2132篇 |
2017年 | 2756篇 |
2016年 | 2231篇 |
2015年 | 3826篇 |
2014年 | 4739篇 |
2013年 | 6161篇 |
2012年 | 7620篇 |
2011年 | 8018篇 |
2010年 | 7472篇 |
2009年 | 6831篇 |
2008年 | 6471篇 |
2007年 | 6187篇 |
2006年 | 5455篇 |
2005年 | 4255篇 |
2004年 | 2955篇 |
2003年 | 2378篇 |
2002年 | 1888篇 |
2001年 | 1796篇 |
2000年 | 1208篇 |
1999年 | 589篇 |
1998年 | 402篇 |
1997年 | 415篇 |
1996年 | 405篇 |
1995年 | 331篇 |
1994年 | 265篇 |
1993年 | 249篇 |
1992年 | 157篇 |
1991年 | 126篇 |
1990年 | 118篇 |
1989年 | 142篇 |
1988年 | 125篇 |
1987年 | 106篇 |
1986年 | 109篇 |
1985年 | 98篇 |
1984年 | 79篇 |
1983年 | 81篇 |
1982年 | 64篇 |
1981年 | 67篇 |
1980年 | 45篇 |
1979年 | 24篇 |
1978年 | 25篇 |
1977年 | 36篇 |
1976年 | 32篇 |
1954年 | 20篇 |
Methods: Twelve healthy volunteers completed this randomized, double-blind, crossover study. Ventilatory responses to carbon dioxide and to isocapnic hypoxia were determined during four treatment phases: (1) baseline, (2) alfentanil infusion; (3) combined midazolam and alfentanil infusions, and (4) combined alfentanil, midazolam, and "study drug" (consisting of either flumazenil or flumazenil vehicle) infusions. Subjects returned 2-6 weeks later to receive the alternate study drug.
Results: Alfentanil decreased the slope of the carbon dioxide response curve from 2.14 +/- 0.40 to 1.43 +/- 0.19 l [dot] min sup -1 [dot] mmHg sup -1 (x +/- SE, P < 0.05), and decreased the minute ventilation at PET CO2 = 50 mmHg (V with dotE 50) from 19.7 +/- 1.2 to 14.8 +/- 0.9 l [dot] min sup -1 (P < 0.05). Midazolam further reduced these variables to 0.87 +/- 0.17 l [dot] min sup -1 [dot] mmHg sup -1 (P < 0.05) and 11.7 +/- 0.8 l [dot] min sup -1 (P <0.05), respectively. With addition of flumazenil, slope and V with dot sub E 50 increased to 1.47 +/- 0.37 l [dot] min sup -1 [dot] mmHg sup -1 (P < 0.05) and 16.4 +/- 2.0 l [dot] min sup -1 (P < 0.05); after placebo, the respective values of 1.02 +/- 0.19 l [dot] min sup -1 [dot] mmHg sup -1 and 12.5 +/- 1.2 l [dot] min sup -1 did not differ significantly from their values during combined alfentanil and midazolam administration. The effect of flumazenil differed significantly from that of placebo (P < 0.05). Both the slope and the displacement of the hypoxic ventilatory response, measured at PET CO2 = 46 +/- 1 mmHg, were affected similarly, with flumazenil showing a significant improvement compared to placebo. 相似文献
Methods. A retrospective cross‐sectional survey using a structured telephone interview. Three cancer screening clinics at an urban inner‐city public hospital. All women with abnormal screening mammograms between September 1990 and January 1992 were eligible; women were interviewed in August 1992. Abnormal mammograms were those requiring specific, non‐routine clinical follow‐up; non‐compliance was defined as delayed follow‐up (four to six months after the date of the mammogram), or no follow‐up at the time of interview (more than 6 months after abnormal).
Results. Sixty‐two of 442 screened women had abnormal results; the overall rate of non‐compliance with follow‐up was 50%. Among the 42 (68%) women who agreed to be interviewed, non‐compliers were less likely to state that they had been told to receive follow‐up than compilers (65% versus 100%; p = 0.008). Non‐compliant women were less likely to have suspicious mammography interpretations (p = 0.05), and more likely to report barriers to follow‐up, such as cost of lost wages and medical care, system barriers, or fears, than compliant women (61.9% versus 9%, p = 0.01). There were no differences between the two groups for age, education, insurance, source of care, family history, knowledge or attitudes.
Conclusions. These preliminary results suggest that follow‐up of low income, minority women with abnormal screening mammograms could be enhanced by improved communication of results. Future studies should extend these findings with larger samples and in other settings and populations. 相似文献